Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer

BACKGROUND: Expression of programmed death-ligand 1 (PD-L1) has been reported to correlate with response to immune checkpoint inhibitors (ICIs) in various tumor types. However, there are few data on the role of PD-L1 expression as a predictive and prognostic biomarker of sensitivity to ICIs in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hongsik, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Ha, Sang Yun, Park, Joon Oh, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386848/
https://www.ncbi.nlm.nih.gov/pubmed/35992188
http://dx.doi.org/10.1177/17562848221117638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386848/
https://www.ncbi.nlm.nih.gov/pubmed/35992188
http://dx.doi.org/10.1177/17562848221117638

Ejemplares similares